Search - tctmd.com

Displaying 81 - 100 of 234

Sort: Relevancy | Date

News Daily News

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Michael O'Riordan

March 31, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Daily News

Worse CABG Outcomes in Women Haven’t Budged in Over a Decade: STS

L.A. McKeown

March 03, 2023

News Daily News

FFR Pullback Measure Linked to Likelihood of Angina Relief After PCI

Todd Neale

December 02, 2022

News Conference News AHA 2022

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

Shelley Wood

November 10, 2022

News Daily News

INOCA Exerts Heavy Toll on Daily Life: Survey

Caitlin E. Cox

September 28, 2022

Presentation TCT 2022

Coronary Sinus Reduction for the Treatment of Symptomatic Microvascular Coronary Disease: Early Clinical Results

Presenter: Shmuel Banai

September 19, 2022

Presentation TCT 2022

TCT 305: The effect of diltiazem versus placebo on microvascular dysfunction assessed by serial continuous thermodilution measurements: results of the EDIT-CMD trial.

Presenter: Tijn Jansen

September 19, 2022

Presentation TCT 2022

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

Presenter: Shinichiro Masuda

September 19, 2022

Presentation TCT 2022

TCT 303: Continuous versus bolus thermodilution derived CFR and MRR and their association with symptoms of CMD: a head-to-head comparison

Presenter: Tijn Jansen

September 19, 2022

Presentation TCT 2022

TCT 302: MRR by Continuous Thermodilution is not Influenced by the Ray Flow Catheter Effect on Coronary Resistance

Presenter: Alejandro Gutierrez-Barrios

September 19, 2022

Presentation TCT 2022

TCT 301: The role of the collateral circulation in stable coronary artery disease: a placebo-controlled study in patients with stable angina.

Presenter: Christopher Rajkumar

September 19, 2022

Presentation TCT 2022

TCT 300: The impact of coronary microvascular dysfunction on fractional flow reserve and resting full-cycle ratio discordance in the assessment of borderline coronary lesions

Presenter: Piotr Szolc

September 18, 2022

Presentation TCT 2022

TCT 298: Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular Death

Presenter: David Hong

September 18, 2022

Presentation TCT 2022

TCT 297: Prevalence of Coronary Microvascular Disease in Patients with Non-Obstructive Coronary Artery Disease

Presenter: Carlos Collet

September 18, 2022

Presentation TCT 2022

TCT 296: Post-Spastic Flow Recovery Time to Document Vasospasm Induced Ischemia during Acetylcholine Provocation Testing.

Presenter: Janneke Woudstra

September 18, 2022

Presentation TCT 2022

TCT 295: Periprocedural Angiography-Derived Index of Microvascular Resistance in Patients With Multivessel Disease: Perspective From Multivessel TALENT Trial

Presenter: SHIGETAKA KAGEYAMA

September 18, 2022

Presentation TCT 2022

Case #3: Symptomatic Microvascular Disease

Presenter: Nils Johnson

September 17, 2022

News Conference News ESC 2022

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Shelley Wood

August 28, 2022

News Daily News

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

Yael L. Maxwell

June 03, 2022

Advertisement

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Worse CABG Outcomes in Women Haven’t Budged in Over a Decade: STS

FFR Pullback Measure Linked to Likelihood of Angina Relief After PCI

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

INOCA Exerts Heavy Toll on Daily Life: Survey

Coronary Sinus Reduction for the Treatment of Symptomatic Microvascular Coronary Disease: Early Clinical Results

TCT 305: The effect of diltiazem versus placebo on microvascular dysfunction assessed by serial continuous thermodilution measurements: results of the EDIT-CMD trial.

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

TCT 303: Continuous versus bolus thermodilution derived CFR and MRR and their association with symptoms of CMD: a head-to-head comparison

TCT 302: MRR by Continuous Thermodilution is not Influenced by the Ray Flow Catheter Effect on Coronary Resistance

TCT 301: The role of the collateral circulation in stable coronary artery disease: a placebo-controlled study in patients with stable angina.

TCT 300: The impact of coronary microvascular dysfunction on fractional flow reserve and resting full-cycle ratio discordance in the assessment of borderline coronary lesions

TCT 298: Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular Death

TCT 297: Prevalence of Coronary Microvascular Disease in Patients with Non-Obstructive Coronary Artery Disease

TCT 296: Post-Spastic Flow Recovery Time to Document Vasospasm Induced Ischemia during Acetylcholine Provocation Testing.

TCT 295: Periprocedural Angiography-Derived Index of Microvascular Resistance in Patients With Multivessel Disease: Perspective From Multivessel TALENT Trial

Case #3: Symptomatic Microvascular Disease

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content